ESTRO-ACROP recommendations for evidence-based use of androgen deprivation therapy in combination with external-beam radiotherapy in prostate cancer
NS Schmidt-Hegemann, C Zamboglou… - Radiotherapy and …, 2023 - Elsevier
Background and purpose There is no consensus concerning the appropriate use of
androgen deprivation therapy (ADT) during primary and postoperative external-beam …
androgen deprivation therapy (ADT) during primary and postoperative external-beam …
68Ga-PSMA Cerenkov luminescence imaging in primary prostate cancer: first-in-man series
J Olde Heuvel, BJ de Wit-van der Veen… - European journal of …, 2020 - Springer
Abstract Purpose Currently, approximately 11–38% of prostate cancer (PCa) patients
undergoing radical prostatectomy have a positive surgical margin (PSM) on histopathology …
undergoing radical prostatectomy have a positive surgical margin (PSM) on histopathology …
The effect of salvage radiotherapy and its timing on the health-related quality of life of prostate cancer patients
Background The impact of salvage radiotherapy (SRT) and its timing on health-related
quality of life (HRQoL) in prostate cancer patients is still unclear. Objective To compare the …
quality of life (HRQoL) in prostate cancer patients is still unclear. Objective To compare the …
Progress and controversies: Radiation therapy for prostate cancer
NE Martin, AV D'Amico - CA: a cancer journal for clinicians, 2014 - Wiley Online Library
Answer questions and earn CME/CNE Radiation therapy remains a standard treatment
option for men with localized prostate cancer. Alone or in combination with androgen …
option for men with localized prostate cancer. Alone or in combination with androgen …
Imaging biomarkers in prostate cancer: role of PET/CT and MRI
M Picchio, P Mapelli, V Panebianco… - European journal of …, 2015 - Springer
Prostate-specific antigen (PSA) is currently the most widely used biomarker of prostate
cancer (PCa). PSA suggests the presence of primary tumour and disease relapse after …
cancer (PCa). PSA suggests the presence of primary tumour and disease relapse after …
Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER)
Background Ultra-hypofractionated image-guided stereotactic body radiotherapy (SBRT) is
increasingly used for definitive treatment of localized prostate cancer. Magnetic resonance …
increasingly used for definitive treatment of localized prostate cancer. Magnetic resonance …
Preoperative prediction of extracapsular extension: radiomics signature based on magnetic resonance imaging to stage prostate cancer
S Ma, H Xie, H Wang, J Yang, C Han, X Wang… - Molecular imaging and …, 2020 - Springer
Purpose To investigate and validate the potential role of a radiomics signature in predicting
the side-specific probability of extracapsular extension (ECE) of prostate cancer (PCa) …
the side-specific probability of extracapsular extension (ECE) of prostate cancer (PCa) …
Location of recurrence by Gallium-68 PSMA-11 PET scan in prostate cancer patients eligible for salvage radiotherapy
Objective To identify locations of recurrence after radical prostatectomy (RP) with prostate-
specific antigen (PSA)< 2 by Gallium-68 prostate-specific membrane antigen (PSMA)-11 …
specific antigen (PSA)< 2 by Gallium-68 prostate-specific membrane antigen (PSMA)-11 …
Localized and locally advanced prostate cancer: treatment options
Background: There are many treatment options for localized and locally advanced prostate
cancer with radiotherapy and surgery representing the main local therapeutic strategies …
cancer with radiotherapy and surgery representing the main local therapeutic strategies …
Circulating miRNAs as non-invasive biomarkers to predict aggressive prostate cancer after radical prostatectomy
Background Prostate cancer is an extremely heterogeneous disease. Despite being
clinically similar, some tumours are more likely to recur after surgery compared to others …
clinically similar, some tumours are more likely to recur after surgery compared to others …